The lancet. Healthy longevity

How Frailty May Affect mRNA Vaccine Effectiveness

Updated

Abstract

Frailty is associated with weaker or less durable responses to COVID-19 lipid nanoparticle mRNA vaccines compared to non-frail individuals.

  • Frailty can lead to increased vulnerability to infection and impaired vaccine response.
  • Alterations in blood cell production, chronic inflammation, and immune system dysfunction are linked to frailty-related immunosenescence.
  • Evidence suggests that people with frailty may show heterogeneous responses to vaccination.
  • Lipid nanoparticle mRNA vaccines offer opportunities for customization to better suit individuals with frailty.
  • Optimizing vaccine components and addressing comorbidities and nutrition may improve vaccination outcomes for older adults.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free